- Home
- Industry Reports
- Biotechnology
- Healthcare
- Europe Smart Pills Drug Delivery Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Smart pills or nootropics are small medical and embedded electronic devices such as sensors, cameras, and trackers which can be quickly swallowed and provides a complete evaluation of the gastrointestinal tract. Drug delivery is an approach, technology or a system for transporting medicine inside the body via drug chemical and by drug-device products. Smart pills have reduced the difference between digital and healthcare technology. However, real-time patient monitoring is possible with intelligent pills diagnostics and can record bodily functions of the patients.
Europe Smart Pills Drug Delivery Market Segments Size & Growth:
Europe Smart Pills Drug Delivery Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are due to the prevalence of Gastro-Intestinal diseases; it reduces invasive surgeries, technological developments in capsule endoscopy, personalised medicine, and reimbursement policies. However, lack of skilled professionals, expensive treatment, and ethical issues hinder the growth of the Europe smart pills drug delivery market.
Europe Smart Pills Drug Delivery Market Segments Share:
Europe Smart Pills Drug Delivery Market is categorised into by type which consists ofIntelliCap CR and IntelliCap FR. IntelliCap FR has the most significant share due to its design capabilities for use in clinical trials for drug delivery in the gastrointestinal tract, along with recording conditions in the body. IntelliCap FR delivers the drug in the form of solids, powder, and semi-solid into the patient’s body.
By Geography, Germany is dominating the smart pills drug delivery market, and the growth in Europe is mainly attributed because of the increasing non-invasive diagnosis and advancement personalised medicine. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising ageing population, awareness about GI tract and demand for precision medicine.
Europe Smart Pills Drug Delivery Market Segments Trends:
- In November 2016, research of MIT and Brigham has manufactured a new capsule that remains for a long-term and slowly delivery its drug to overcome problems will treatment and curing diseases like malaria.
- In March 2017, Boston Scientific Corporation acquired Symetis SA this will help expand valvular heart treatment for some patients.
Europe Smart Pills Diagnostics Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- AdhereTech
- IntroMedic Co., Ltd.,
- GE Healthcare
- MicroChips
- Boston Scientific Corporation
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Rising prevalence of Gastro-Intestinal diseases.
4.1.2 Preference for minimally invasive surgeries
4.1.3 Technological developments in capsule endoscopes.
4.2 Restraints
4.2.1 Raising ethical issues in medical conditions
4.2.2 Lack skilled professionals.
4.2.3 High cost.
4.3 Opportunities
4.3.1 Precisely locate chronic diseases and disorders.
4.4 Challenges
4.4.1.Reduce side effects
4.4.2. Cost effective pills.
Chapter 5 Europe Smart Pills Drug Delivery Market- By Type
5.1 IntelliCap CR
5.2 IntelliCap FR
Chapter 6 Europe Smart Pills Drug Delivery Market- By Geography
6.1 Introduction
6.2 Europe
6.2.1. U.K.
6.2.2. Germany
6.2.3. France
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
Chapter 7 Europe Smart Pills Drug Delivery Market- Company Profiles
7.1. Medimetrics S.A. De C.V.
7.2.Pixie Scientific
7.3.Capsovision Inc.
7.4.Azoi
7.5.Medisafe
7.6.AdhereTech
7.7.IntroMedic Co., Ltd.,
7.8.GE Healthcare
7.9.MicroChips
7.10.Boston Scientific Corporation
7.11.Bio-Images Research Ltd
7.12.Vitality
7.13.Proteus Pharmaceuticals
7.14.Given Imaging Ltd
7.15.Olympus Medical Technology
Chapter 8 Europe Smart Pills Drug Delivery Market- Competitive Landscape
8.1.Market Share Analysis
8.2.Strategies Adopted by top companies
8.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2.Analysts Opinions
9.3.Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Smart pills or nootropics are small medical and embedded electronic devices such as sensors, cameras, and trackers which can be quickly swallowed and provides a complete evaluation of the gastrointestinal tract. Drug delivery is an approach, technology or a system for transporting medicine inside the body via drug chemical and by drug-device products. Smart pills have reduced the difference between digital and healthcare technology. However, real-time patient monitoring is possible with intelligent pills diagnostics and can record bodily functions of the patients.
Europe Smart Pills Drug Delivery Market Segments Size & Growth:
Europe Smart Pills Drug Delivery Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth are due to the prevalence of Gastro-Intestinal diseases; it reduces invasive surgeries, technological developments in capsule endoscopy, personalised medicine, and reimbursement policies. However, lack of skilled professionals, expensive treatment, and ethical issues hinder the growth of the Europe smart pills drug delivery market.
Europe Smart Pills Drug Delivery Market Segments Share:
Europe Smart Pills Drug Delivery Market is categorised into by type which consists ofIntelliCap CR and IntelliCap FR. IntelliCap FR has the most significant share due to its design capabilities for use in clinical trials for drug delivery in the gastrointestinal tract, along with recording conditions in the body. IntelliCap FR delivers the drug in the form of solids, powder, and semi-solid into the patient’s body.
By Geography, Germany is dominating the smart pills drug delivery market, and the growth in Europe is mainly attributed because of the increasing non-invasive diagnosis and advancement personalised medicine. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising ageing population, awareness about GI tract and demand for precision medicine.
Europe Smart Pills Drug Delivery Market Segments Trends:
- In November 2016, research of MIT and Brigham has manufactured a new capsule that remains for a long-term and slowly delivery its drug to overcome problems will treatment and curing diseases like malaria.
- In March 2017, Boston Scientific Corporation acquired Symetis SA this will help expand valvular heart treatment for some patients.
Europe Smart Pills Diagnostics Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- AdhereTech
- IntroMedic Co., Ltd.,
- GE Healthcare
- MicroChips
- Boston Scientific Corporation
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 Rising prevalence of Gastro-Intestinal diseases.
4.1.2 Preference for minimally invasive surgeries
4.1.3 Technological developments in capsule endoscopes.
4.2 Restraints
4.2.1 Raising ethical issues in medical conditions
4.2.2 Lack skilled professionals.
4.2.3 High cost.
4.3 Opportunities
4.3.1 Precisely locate chronic diseases and disorders.
4.4 Challenges
4.4.1.Reduce side effects
4.4.2. Cost effective pills.
Chapter 5 Europe Smart Pills Drug Delivery Market- By Type
5.1 IntelliCap CR
5.2 IntelliCap FR
Chapter 6 Europe Smart Pills Drug Delivery Market- By Geography
6.1 Introduction
6.2 Europe
6.2.1. U.K.
6.2.2. Germany
6.2.3. France
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
Chapter 7 Europe Smart Pills Drug Delivery Market- Company Profiles
7.1. Medimetrics S.A. De C.V.
7.2.Pixie Scientific
7.3.Capsovision Inc.
7.4.Azoi
7.5.Medisafe
7.6.AdhereTech
7.7.IntroMedic Co., Ltd.,
7.8.GE Healthcare
7.9.MicroChips
7.10.Boston Scientific Corporation
7.11.Bio-Images Research Ltd
7.12.Vitality
7.13.Proteus Pharmaceuticals
7.14.Given Imaging Ltd
7.15.Olympus Medical Technology
Chapter 8 Europe Smart Pills Drug Delivery Market- Competitive Landscape
8.1.Market Share Analysis
8.2.Strategies Adopted by top companies
8.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 9 Market Insights
9.1. Industry Experts Insights
9.2.Analysts Opinions
9.3.Investment Opportunities
Chapter 10 Appendix
10.1 List of Tables
10.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.